Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Recombinant Human Syndecan-1 Protein (Fc Chimera 6xHis Tag) (AC1107)
Cat.#: ACPP-1107
Specifications
Despition Recombinant Human Syndecan-1 Protein (Fc Chimera 6xHis Tag) for ELISA, SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence CD138 (Gln23-Gly254) + hFc (Glu99-Ala330) + 6×His Tag Molecular Weight 50.8 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Human Fc Tag and 6×His Tag Applications ELISA, SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1788 Human NEUROG3 Protein (AC1788) 2 µg inquiry ACPP-1058 Recombinant Human TrkA Protein (Fc Tag) (AC1058) 50 µg inquiry ACPP-1120 Human NRG1 Protein (AC1120) 10 µg inquiry ACPP-1407 Human HOMER3 Protein (AC1407) 5 µg inquiry ACPP-1297 p75 NGF Receptor Blocking Peptide (AC1297) 250 µg inquiry ACPP-1666 Human LGALS3 Protein, His (AC1666) 5 µg inquiry ACPP-1313 Norepinephrine Transporter Blocking Peptide (AC1313) 250 µg inquiry ACPP-1811 Human HSD17B8 Protein (AC1811) 5 µg inquiry ACPP-1216 PARD3 Blocking Peptide (AC1216) 250 µg inquiry ACPP-1487 Human Pleiotrophin Protein (AC1487) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket